Covidien to Acquire Oridion Systems for $300M
Covidien has announced it will acquire Israel-based Oridion Systems for approximately $300 million, according to a news release.
Oridion Systems develops Microstream capnography monitors and modules as well as etCO2 breath sampling lines. These products monitor adequacy of ventilation.
"The acquisition of Oridion Systems adds a key monitoring technology to the Covidien portfolio," said Robert J. White, president of respiratory and monitoring systems for Covidien, in the release. "Oridion's products and etCO2 technology are excellent complements to the Company’s current portfolio of pulse oximeters and monitoring products, enabling us to offer a complete portfolio of solutions to monitor respiratory function for patients around the world."
The companies expect to complete the merger in the second calendar quarter of 2012.
Related Articles on Company Acquisitions:
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
- How Physician Thinking Changes After Working in ACOs
- 2014 Financial Impact Analysis Doesn't Stop With CMS' Final Rule: Don't Neglect CMS NCCI Edits
- 4 Drivers of Recent M&A Activity in Healthcare
- 8 Reasons to Outsource Medical Billing Services
- 5 ICD-10 Transition Considerations Medical Practices Have Likely Not Thought About